Jereme M. Sylvain - 06 Dec 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP, Chief Financial Officer
Signature
Jereme M. Sylvain
Issuer symbol
DXCM
Transactions as of
06 Dec 2021
Net transactions value
-$310,554
Form type
4
Filing time
06 Dec 2021, 18:16:11 UTC
Previous filing
10 Nov 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale $310,554 -600 -4.7% $517.59 12,292 06 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 4, 2021, Mr. Sylvain adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sylvain. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 Included in this number are 9,759 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,654 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 804 of which were granted on March 8, 2019 and shall vest through March 8, 2022.